at Zacks.com (Jan 15, 2015)
BioCryst (BCRX -4.7%) trades lower today following the announcement that its investigational new drug BCX4161 has been put on a clinical hold due to manufacturing issues. JMP Securities cut the shares to Market Perform on the news.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at MarketWatch.com (Jan 14, 2015)
at Zacks.com (Jan 14, 2015)
at Benzinga.com (Jan 14, 2015)
at CNBC.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs